CD274 and hepatocellular carcinoma: The HCC immune landscape shows that approximately 25% of cases have a high degree of immune infiltration (so-called ‘immune class’ of HCC), with high expression levels of PD-1/PD-L1 [73,74,75] and likely well suited for PD-1-blocking immunotherapy.